DEA clarifies synthetic cannabis component is illegal (Newsletter: May 4, 2026)
PA gov slams opponent’s legalization opposition; MD gov signs psychedelics bill; TX hemp rulings; CA eases biz transition for rescheduling benefits Subscribe to receive Marijuana Moment’s newsletter …
Missouri Lawsuit Targets ‘Cartel’ That’s Allegedly ‘Seized Control’ Of State’s Marijuana Market
The GDF Cartel has—through a combination of price-fixing, product- and supplier-allocation agreements, and coordinated exclusionary conduct—unlawfully seized control of the Missouri retail dispensary …
Why Trump’s marijuana policy shift could reshape the cannabis industry
A quiet regulatory change on medical marijuana could mean lower taxes, fresh investment and a turning point for a sector that has struggled under federal restrictions.
As recreational cannabis takes root in East Grand Forks, other states offer clues to the industry’s future
With the Friday grand opening of Waabigwan Mashkiki, the White Earth Nation-owned dispensary, the legalization of adult-use cannabis has officially arrived in East Grand …
‘Game is not over.’ Puff promises appeal in U.P. cannabis clash
The company has filed a separate lawsuit against competitor Lume Cannabis, alleging the rival chain secretly funded a ballot initiative to cap marijuana licenses in the Wisconsin border town.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Napa’s first cannabis-infused rosé maker files for bankruptcy
Preview this article 1 min The Napa-based beverage maker reported up to $500,000 in liabilities. Its collapse follows the apparent closure of several direct competitors in the region. One of the Bay …
Next-Gen Cannabis: The Innovative Race to Manufacture Compounds
Cannabis business operators and advisors have spent the last several years watching the market evolve from a THC-and-CBD story into something much more nuanced.
US reclassifies weed: Can cannabis ETFs give your portfolio a new high?
In a landmark policy shift, the Trump administration reclassified medical marijuana from a Schedule I to a Schedule III controlled substance in late April 2026, marking the most significant federal …
Europe’s Cannabis Boom Is Accelerating as Billions Flow into Licensed Markets
Herbal Dispatch has established a growing international medical cannabis commercialization network spanning multiple regulated global markets including Australia, Portugal, Germany, Brazil, Czech …
Your guide to L.A. City Measure CB: taxing illegal cannabis businesses
L.A.’s measure CB represents a hope to crack down on illegal cannabis businesses by closing a legal loophole. Opponents say the measure may normalize illegal activity.
The US government didn’t legalize marijuana: 4 cannabis misconceptions explained
The federal government’s reclassification of medical marijuana products as Schedule III drugs doesn’t federally legalize marijuana, but it might extend tax breaks to some cannabis businesses. …
Companies with cannabis-based drugs eye IPOs, private funding boost after US reclassification
By Puyaan Singh and Christy Santhosh April 30 (Reuters) – Companies developing cannabis-based medicines say U.S. moves to loosen restrictions on the drug could unlock private funding and the public …
It Ain’t Just Bud: Black-Owned Brands That Contribute To The Cannabis Industry
How big is the Black-owned cannabis market? The legal cannabis industry generates billions of dollars annually—reaching an estimated $40 billion in 2024—but suffers from a significant imbalance in …
How MSO TerrAscend is leading the cannabis industry forward
TerrAscend will leverage federal rescheduling of medical cannabis to drive growth, shape policy with a focus on compliance and expansion.
Recent Comments